---
figid: PMC5539435__fendo-08-00182-g002
figtitle: Multiple-injections of lipopolysaccharide (LPS) is effective in preventing
  type 1 diabetes mellitus (type 1 DM)
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC5539435
filename: fendo-08-00182-g002.jpg
figlink: /pmc/articles/PMC5539435/figure/F2/
number: F2
caption: Multiple-injections of lipopolysaccharide (LPS) is effective in preventing
  type 1 diabetes mellitus (type 1 DM). LPS administration suppresses spleen T lymphocyte
  proliferation, increases the generation of T regulatory, reduces the synthesis of
  T-helper 1 pro-inflammatory cytokines [interleukin-2 (IL-2), interleukin-1 (IL-1),
  interferon-γ (IFN-γ), and tumor necrosis factor-α (TNF-α)], and downregulates toll-like
  receptor-4 (TLR-4) and its downstream MyD88-dependent signaling pathway and enhances
  IL-4 and IL-10 and antioxidant defenses. Multiple injections of LPS induce tolerogenic
  dendritic cell (DC) subset with low TLR-4 expression and, thus, prevent development
  of type 1 DM in non-obese diabetic mice [see text and Wang et al. ()].
papertitle: Is There a Role for Bioactive Lipids in the Pathobiology of Diabetes Mellitus?.
reftext: Undurti N. Das. Front Endocrinol (Lausanne). 2017;8:182.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.891962
figid_alias: PMC5539435__F2
figtype: Figure
redirect_from: /figures/PMC5539435__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5539435__fendo-08-00182-g002.html
  '@type': Dataset
  description: Multiple-injections of lipopolysaccharide (LPS) is effective in preventing
    type 1 diabetes mellitus (type 1 DM). LPS administration suppresses spleen T lymphocyte
    proliferation, increases the generation of T regulatory, reduces the synthesis
    of T-helper 1 pro-inflammatory cytokines [interleukin-2 (IL-2), interleukin-1
    (IL-1), interferon-γ (IFN-γ), and tumor necrosis factor-α (TNF-α)], and downregulates
    toll-like receptor-4 (TLR-4) and its downstream MyD88-dependent signaling pathway
    and enhances IL-4 and IL-10 and antioxidant defenses. Multiple injections of LPS
    induce tolerogenic dendritic cell (DC) subset with low TLR-4 expression and, thus,
    prevent development of type 1 DM in non-obese diabetic mice [see text and Wang
    et al. ()].
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IRF6
  - MYD88
  - TLR4
  - IL10
  - IL4
  - TNF
  - IL2
  - IL11
---
